These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23842688)
1. Ramipril improves walking times and quality of life in patients with stable intermittent claudication. Brittenden J Evid Based Med; 2014 Feb; 19(1):16. PubMed ID: 23842688 [No Abstract] [Full Text] [Related]
2. ACP Journal Club. Ramipril improved walking times and QOL in peripheral artery disease and intermittent claudication. Jaar BG Ann Intern Med; 2013 Jun; 158(12):JC7. PubMed ID: 23778931 [No Abstract] [Full Text] [Related]
3. Ramipril for treatment of intermittent claudication. Poredos P Vasa; 2013 Jul; 42(4):237-8. PubMed ID: 23823855 [No Abstract] [Full Text] [Related]
4. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460. Kurklinsky AK; Levy M Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841 [TBL] [Abstract][Full Text] [Related]
6. Medications for improving walking performance in peripheral artery disease: still miles to go. McDermott MM JAMA; 2013 Feb; 309(5):487-8. PubMed ID: 23385276 [No Abstract] [Full Text] [Related]
8. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271 [TBL] [Abstract][Full Text] [Related]
9. Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication. Ahimastos AA; Latouche C; Natoli AK; Reddy-luthmoodoo M; Golledge J; Kingwell BA Circ Res; 2014 Mar; 114(7):1144-55. PubMed ID: 24397981 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease. Hunter MR; Cahoon WD; Lowe DK Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767 [TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication. Shahin Y; Cockcroft JR; Chetter IC Br J Surg; 2013 Aug; 100(9):1154-63. PubMed ID: 23842829 [TBL] [Abstract][Full Text] [Related]
12. Summaries for patients. Ramipril improves walking ability in patients with peripheral arterial disease. Ann Intern Med; 2006 May; 144(9):I24. PubMed ID: 16670129 [No Abstract] [Full Text] [Related]
13. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ahimastos AA; Lawler A; Reid CM; Blombery PA; Kingwell BA Ann Intern Med; 2006 May; 144(9):660-4. PubMed ID: 16670135 [TBL] [Abstract][Full Text] [Related]
14. Effect of ramipril on renal function in patients with intermittent claudication. Hobbs SD; Claridge MW; Wilmink AB; Adam DJ; Thomas ME; Bradbury AW Vasc Health Risk Manag; 2008; 4(2):471-5. PubMed ID: 18561523 [TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication. Shahin Y; Barnes R; Barakat H; Chetter IC Atherosclerosis; 2013 Dec; 231(2):283-90. PubMed ID: 24267241 [TBL] [Abstract][Full Text] [Related]
16. Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials. Shahin Y; Mazari F; Chetter I Int J Surg; 2011; 9(3):209-13. PubMed ID: 21195215 [TBL] [Abstract][Full Text] [Related]